Table of Contents
Organic Chemistry International
Volume 2014 (2014), Article ID 419518, 5 pages
http://dx.doi.org/10.1155/2014/419518
Research Article

Synthesis, Characterization, and Evaluation for Antibacterial and Antifungal Activities of N-Heteroaryl Substituted Benzene Sulphonamides

Synthetic Organic Chemistry Division, Department of Pure and Industrial Chemistry, University of Nigeria, Nigeria

Received 2 May 2014; Revised 6 August 2014; Accepted 6 August 2014; Published 27 November 2014

Academic Editor: Joseph E. Saavedra

Copyright © 2014 Christiana Nonye Igwe and Uchechukwu Chris Okoro. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Casini, A. Scozzafava, and C. T. Supuran, “Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents,” Expert Opinion on Therapeutic Patents, vol. 12, no. 9, pp. 1307–1327, 2002. View at Google Scholar
  2. Sulphanomide—Medicine, “The Free Encyclopedia,” 2009, http://en.wikipedia.org/wiki/su/fonamide.
  3. C. T. Supuran, A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, and G. Mincione, “Carbonic anhydrase inhibitors. Part 71: synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties,” European Journal of Pharmaceutical Sciences, vol. 8, no. 4, pp. 317–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Remko and C.-W. von der Lieth, “Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides,” Bioorganic & Medicinal Chemistry, vol. 12, no. 20, pp. 5395–5403, 2004. View at Publisher · View at Google Scholar
  5. A. K. Gaded, C. S. Mahajanshetti, A. Nimbalkar, and A. Raichurkar, “Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfon amide derivatives,” European Journal of Medicinal Chemistry, vol. 35, no. 9, pp. 853–857, 2003. View at Google Scholar
  6. N. S. El-Sayed, E. R. El-Bendary, S. M. El-Ashry, and M. M. El-Kerdawy, “Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines,” European Journal of Medicinal Chemistry, vol. 46, no. 9, pp. 3714–3720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Garcia-Galan, M. S. Diaz-Cruz, and D. Bercelo, “Identification and determination of metabolites and degradation products of sulfonamide antibiotics,” Trends in Analytical Chemistry, vol. 27, no. 11, pp. 1008–1022, 2008. View at Google Scholar
  8. C. T. Supuran, A. Casini, and A. Scozzafava, “Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents,” Medicinal Research Reviews, vol. 23, no. 5, pp. 535–558, 2003. View at Google Scholar
  9. A. Scozzafava, T. Owa, A. Mastrolorenzo, and C. T. Supuran, “Anticancer and antiviral sulfonamides,” Current Medicinal Chemistry, vol. 10, no. 11, pp. 925–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. W. G. Harter, H. Albrect, K. Brady et al., “The design and synthesis of sulfonamides as caspase-1 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 3, pp. 809–812, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. S. Reddy, M. R. Mallireddigari, S. Cosenza et al., “Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 15, pp. 4093–4097, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. B. R. Stranix, J. F. Lavallee, G. Sevigny et al., “Lysine sulfonamides as novel HIV-protease inhibitors: Nε-Acyl aromatic α-amino acids,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 13, pp. 3459–3462, 2006. View at Google Scholar
  13. K. K. Anderson and D. N. Jones, vol. 3, Pergamon Press, Oxford, UK, 1979.
  14. A. Yasuhara, M. Kameda, and T. Sakamoto, “Selective monodesulfonylation of N, N-disulfonylarylamines with tetrabutylammonium fluoride,” Chemical and Pharmaceutical Bulletin, vol. 47, no. 6, pp. 809–812, 1999. View at Publisher · View at Google Scholar
  15. J. F. O'Connell and H. Rapoport, “1-(Benzenesulfonyl)- and 1-(p-toluenesulfonyl)-3-methylimidazolium triflates: efficient reagents for the preparation of arylsulfonamides and arylsulfonates,” Journal of Organic Chemistry, vol. 57, no. 17, pp. 4775–4777, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Chandrasekhar and S. Mohapatra, “Neighbouring group assisted sulfonamide cleavage of sharpless aminols under acetonation conditions,” Tetrahedron Letters, vol. 39, no. 7, pp. 695–698, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Gleckman, S. Alvarez, and D. W. Joubert, “Drug therapy reviews: trimethoprim-sulfamethoxazole,” The American Journal of Hospital Pharmacy, vol. 36, no. 7, pp. 893–906, 1979. View at Google Scholar · View at Scopus
  18. S. R. Bushby and G. H. Hitchings, “Trimethoprim, a sulphonamide potentiator,” British Journal of Pharmacology, vol. 33, no. 1, pp. 72–90, 1968. View at Google Scholar · View at Scopus
  19. G. Thomas, Medicinal Chemistry, John Wiley and Sons, 2nd edition, 2007.
  20. N. Ozbek, H. Katircioglu, N. Karacan, and T. Baykal, “Synthesis, characterization and antimicrobial activity of new aliphatic sulfonamide,” Bioorganic and Medicinal Chemistry, vol. 1, no. 15, pp. 5105–5109, 2007. View at Google Scholar
  21. C. O. Vincent, Pharmaceutical Microbiology: Principles of the Pharmaceutical Applications of Antimicrobial Agents, El 'Demak Publishers, Enugu, Nigeria, 2005.
  22. R. Soleymani, N. Niakan, S. Tayeb, and S. Hakimi, “Synthesis of novel aryl quinoxaline derivatives by new catalytic methods,” Oriental Journal of Chemistry, vol. 28, no. 2, pp. 687–701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. K. Anandan, “1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 3, pp. 983–988, 2011. View at Publisher · View at Google Scholar
  24. L. Tietze and F. FMajor, “Synthesis of new water-soluble DNA-binding subunits for analogues of the cytotoxic antibiotic CC-1065 and their prodrugs,” European Journal of Organic Chemistry, vol. 10, pp. 2314–2321, 2006. View at Google Scholar
  25. G. P. Claxton, L. Allen, and J. M. Grisar, “For peptide synthesis, synthesis of 2,3,4,5-tetrahydropyridine,” Organic Syntheses. Collective Volume, vol. 6, p. 968, 1988. View at Google Scholar
  26. K. Shin-Ya, J.-S. Kim, K. Furihata, Y. Hayakawa, and H. Seto, “Structure of kaitocephalin, A novel glutamate receptor antagonist produced by eupenicillium shearii,” Tetrahedron Letters, vol. 38, no. 40, pp. 7079–7082, 1997. View at Publisher · View at Google Scholar · View at Scopus